Biodesign Finland wins the Aalto Pioneering Excellence Award 2025
The Aalto Pioneering Excellence award is granted annually to one or more teams that are doing groundbreaking work
Biodesign Finland is a need-driven medical technology innovation and training program, which produces experts in health technology, solutions to healthcare, and new business.
Biodesign aims to offer the best starting point for creating medical technology for the benefit of the patient globally.
List of Research to Business projects arisen from Biodesign Finland by year (in reverse chronological order, most recent first). Innovation Fellows are highlighted in bold.
Read more on research.aalto.fi
Read more on research.aalto.fi
Read more on research.aalto.fi
Read more on research.aalto.fi
Read more on research.aalto.fi
List of companies that arose from Biodesign Finland (in reverse chronological order, most recent first). Innovation Fellows are highlighted in bold.
The Aalto Pioneering Excellence award is granted annually to one or more teams that are doing groundbreaking work
Aalto University introduces 12 new world-changing innovations at Slush. On of them is digital doula Natal Mind, a mobile app designed to support the emotional and mental journey undergone by mothers-to-be.
The Natal Mind research team won the Polar Bear Pitching competition last weekend in Oulu. Obstetrician Aura Pyykönen tells us what it was like to pitch in the ice-cold water. Annika Järvelin, Riikka Lemmetyinen and Henni Tenhunen are other members of the winning team at Aalto Department of Industrial Engineering and Management.
Researchers are now exploring how to meet the needs of the next century of maternity and child health clinics using Biodesign methods from Stanford University.
The members of the Aalto community have been launching research and development projects related to the corona situation at a rapid pace since March.
New types of biological mesh can also be used in treating gynaecological prolapses, hernias and urinary incontinence.
The Aalto-originated startup Vital Signs will present their innovation at the Slush 100 pitching competition next week.
SpectroCor brings a precise heart monitoring system for open-heart surgery.
The new method developed by Finnish researchers is based on dual-light photodynamic therapy. The method doesn’t interfere with friendly bacteria in the mouth, or cause bacterial resistance
An interdisciplinary team will develop biomedical technologies that can be commercialised.